Biopharmaceutical Stocks List

Biopharmaceutical Stocks Recent News

Date Stock Title
Jul 3 INSM Insmed sees brensocatib NDA for bronchiectasis in Q4
Jul 3 NVO S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3 NVO Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds
Jul 3 NVO Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
Jul 3 NVO Weight-loss drugs linked to rare vision loss: Harvard study
Jul 3 NVO Update: Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
Jul 3 NVO Novo Nordisk’s Ozempic, Wegovy linked to eye disorder in small study
Jul 3 NVO Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
Jul 3 INSM More endpoints met in Insmed’s Phase III brensocatib trial
Jul 3 NVO Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
Jul 3 INSM Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week
Jul 3 SRPT 1 Soaring Growth Stock to Buy and Hold for 10 Years
Jul 3 SRPT Best Momentum Stocks to Buy for July 3rd
Jul 3 INSM Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
Jul 3 REGN Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Jul 3 NVO Should You Hold Novo Nordisk A/S (NVO) for the Long Term?
Jul 3 REGN Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Jul 3 RNA Avidity’s FSHD drug del-brax shows promise in Phase I/II trial
Jul 3 REGN Sanofi, Regeneron win EU label expansion for Dupixent in COPD
Jul 3 REGN Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags